Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CMC Biologics

Request full access

Contract development and manufacturing for biopharmaceutical products

Copenhagen, DenmarkFounded 2001Biotech & Life Sciences

About CMC Biologics

CMC Biologics was a contract development and manufacturing organization (CDMO) founded in Copenhagen, Denmark, in 2001. The company specialized in providing integrated services for the development and manufacturing of protein-based therapeutics, such as monoclonal antibodies and other therapeutic proteins, for clients in the pharmaceutical and biotech industries.

The company's services spanned the entire drug development lifecycle, from cell line and process development to cGMP manufacturing for preclinical, clinical, and commercial use. It operated facilities in Copenhagen, Denmark, and in the U.S. in Seattle, Washington, and Berkeley, California. In 2015, Gustavo Mahler, a biopharmaceutical industry veteran with 20 years of experience, including 15 years at Bayer, became the CEO. Under his leadership, the company experienced significant growth.

In December 2016, a definitive agreement was announced for AGC Asahi Glass (AGC), a Japanese manufacturer of glass and chemicals, to acquire all shares of CMC Biologics for approximately $511 million. This acquisition was part of AGC's strategy to expand its life sciences business. Following the acquisition, in January 2018, CMC Biologics was merged with AGC Bioscience and Biomeva GmbH to form a new global CDMO named AGC Biologics. The new entity, headquartered in Bothell, Washington, combines the expertise and facilities of the merged companies to offer a broader range of services in both microbial and mammalian-based manufacturing across a global network.

Source: Dealroom company data

At a glance

Status
Acquired
Open positions
None listed
Dealroom signal
19.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Hard Tech, DT and LS, science-based

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Dec 2016 $462M $462M AGC ↗
GROWTH EQUITY VCOther financing Feb 2008 $165M — Monitor Clipper Funds · European Equity Partners —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

CMC Biologics website traffic

Latest recorded traffic for CMC Biologics is 240 monthly website visits, down 50% over the last three months.

Latest monthly visits240 3-month web change-50%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

CMC Biologics in the Copenhagen ecosystem

Live from Dealroom

The CMC Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Innoven Partners

Series B and later2 investors entered at this stage

  • Monitor Clipper Funds
  • European Equity Partners

Other known investors1 additional known investor

  • AGC
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇩🇰 Denmark · Copenhagen HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CMC Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CMC Biologics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.